Rampart Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,002
Closed -$319K 119
2020
Q3
$319K Sell
4,002
-1,847
-32% -$144K 0.2% 118
2020
Q2
$404K Buy
5,849
+647
+12% +$46K 0.07% 286
2020
Q1
$327K Sell
5,202
-5,688
-52% -$410K 0.16% 135
2019
Q4
$847K Sell
10,890
-147
-1% -$11.5K 0.1% 247
2019
Q3
$809K Sell
11,037
-669
-6% -$47K 0.1% 244
2019
Q2
$721K Sell
11,706
-735
-6% -$44.4K 0.09% 267
2019
Q1
$793K Buy
12,441
+5,730
+85% +$327K 0.09% 261
2018
Q4
$343K Sell
6,711
-5,019
-43% -$254K 0.1% 185
2018
Q3
$681 Sell
11,730
-11,706
-50% -$573K ﹤0.01% 493
2018
Q2
$1.14M Buy
23,436
+4,515
+24% +$211K 0.11% 251
2018
Q1
$880K Buy
+18,921
New +$822K 0.08% 266
2017
Q4
Sell
-8,547
Closed -$311K 505
2017
Q3
$311K Buy
8,547
+312
+4% +$11.9K 0.11% 216
2017
Q2
$325K Buy
+8,235
New +$301K 0.12% 197

Other funds holding EW

Rampart Investment Management's EW Position: Q4 2020 in Review

Rampart Investment Management sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 4,002 shares — an estimated $319K sold.

Rampart Investment Management first reported a position in EW in Q2 2017 and held it in 13 quarters. The position peaked at $1.14M in Q2 2018. 1,159 funds tracked by Wall St. Rank hold EW as of Q4 2020.

  • Rampart Investment Management reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 4,002 Edwards Lifesciences shares in Q4 2020, an estimated $319K.
  • Rampart Investment Management first reported a position in Edwards Lifesciences in Q2 2017 and held it in 13 quarters.
  • Rampart Investment Management's Edwards Lifesciences position peaked at $1.14M in Q2 2018.
  • 1,159 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.